Survival mechanisms of VEGF and PIGF during microvascular remodeling

Cold Spring Harbor Symposia on Quantitative Biology

Volumn 67, Issue , 2002, Pages 181-187

  Upalakalin, J N ^a   Hemo, I ^b   Dehio, C ^c   Keshet, E ^b   Benjamin, L E ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b HEBREW UNIVERSITY   (Israel)

^c UNIVERSITY OF BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ANGIOPOIETIN; INTEGRIN; NEUROPILIN 1; PLACENTAL GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR BB; PROTEIN; PROTEIN KINASE B; TETRACYCLINE; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 1; CASPASE 3; VASCULOTROPIN A;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; CARDIOVASCULAR SYSTEM; CELL INTERACTION; CELL PROLIFERATION; CELL SURVIVAL; CONFERENCE PAPER; EMBRYO; EMBRYO DEVELOPMENT; ENDOTHELIUM CELL; GENE EXPRESSION; HUMAN; HUMAN CELL; HYPEROXIA; MICROVASCULATURE; NEWBORN; NICK END LABELING; NONHUMAN; OXYGEN CONCENTRATION; OXYGEN TENSION; PERICYTE; PLACENTA; PRIORITY JOURNAL; PROSTATE CANCER; RAT; RETROLENTAL FIBROPLASIA; SIGNAL TRANSDUCTION; TROPHOBLAST; TUMOR VASCULARIZATION; ARTICLE; MORBIDITY; MORTALITY; VASCULAR REMODELING;

ANIMALIA;

EID: 0038801369     PISSN: 00917451     EISSN: None     Source Type: Book Series    
DOI: 10.1101/sqb.2002.67.181     Document Type: Conference Paper

References (81)

1. Adini A., Komaga T., Firoozbakht F., and Benjamin L.E. 2002. Placental growth factor is a survival factor for tumor endothelial cells and macrophages. Cancer Res. 62: 2749.
2. Alon T., Hemo I., Itin A., Pe'er J., Stone J., and Keshet E. 1995. Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity. Nat. Med. 1: 1024.
3. Bachelder R.E., Crago A., Chung J., Wendt M.A., Shaw L.M., Robinson G., and Mercurio A.M. 2001. Vascular endothelial growth factor is an autocrine survival factor for neuropilin-expressing breast carcinoma cells. Cancer Res. 61: 5736.
4. Benjamin L.E., and Keshet E. 1997. Conditional switching of vascular endothelial growth factor (VEGF) expression in tumors: Induction of endothelial cell shedding and regression of hemangioblastoma-like vessels by VEGF withdrawal. Proc. Natl. Acad. Sci. 94: 8761.
5. Benjamin L.E., Hemo I., and Keshet E. 1998. A plasticity window for blood vessel remodelling is defined by pericyte coverage of the preformed endothelial network and is regulated by PDGF-B and VEGF. Development 125: 1591.
6. Benjamin L.E., Golijanin D., Itin A., Pode D., and Keshet E. 1999. Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal (comments). J. Clin. Invest. 103: 159.
7. Berse B., Brown L.F., Van De Water L., Dvorak H.F., and Senger D.R. 1992. Vascular permeability factor (vascular endothelial growth factor) gene is expressed differentially in normal tissues, macrophages, and tumors. Mol. Biol. Cell 3: 211.
8. Cao Y., Linden P., Farnebo J., Cao R., Eriksson A., Kumar V., Qi J.H., Claesson-Welsh L., and Alitalo K. 1998. Vascular endothelial growth factor C induces angiogenesis in vivo. Proc. Natl. Acad. Sci. 95: 14389.
9. Carmeliet P., Ferreira V., Breier G., Pollefeyt S., Kieckens L., Gertsenstein M., Fahrig M., Vandenhoeck A., Harpal K., Eberhardt C., Declercq C., Pawling J., Moons L., Collen D., Risau W., and Nagy A. 1996. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 380: 435.
10. Carmeliet P., Lampugnani M.G., Moons L., Breviario F., Compernolle V., Bono F., Balconi G., Spagnuolo R., Oostuyse B., Dewerchin M., Zanerti A., Angellilo A., Mattot V., Nuyens D., Lutgens E., Clotman F., de Ruiter M.C., Girtenberger-de Groot A., Poelmann R., Lupu F., Herbert J.M., Collen D., and Dejana E. 1999. Targeted deficiency or cytosolic truncation of the VE-cadherin gene in mice impairs VEGF-mediated endothelial survival and angiogenesis. Cell 98: 147.
11. Carmeliet P., Moons L., Luttun A., Vincenti V., Compernolle V., De Mol M., Wu Y., Bono F., Devy L., Beck H., Scholz D., Acker T., DiPalma T., Dewerchin M., Noel A., Stalmans I., Barra A., Blacher S., Vandendriessche T., Ponten A., Eriksson U., Plate K.H., Foidart J.M., Schaper W., Charnock-Jones D.S., Hicklin D.J., Herbert J.M., Collen D., and Persico M.G. 2001. Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions. Nat. Med. 7: 575.
12. Darland D.C., and D'Amore P.A. 1999. Blood vessel maturation: Vascular development comes of age (comment). J. Clin. Invest. 103: 157.
13. Desai J., Holt-Shore V., Torry R.J., Caudle M.R., and Torry D.S. 1999. Signal transduction and biological function of placenta growth factor in primary human trophoblast. Biol. Reprod. 60: 887.
14. Dimmeler S., Fleming I., Fisslthaler B., Hermann C., Busse R., and Zeiher A.M. 1999. Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation. Nature 399: 601.
15. Donnini S., Machein M.R., Plate K.H., and Weich H.A. 1999. Expression and localization of placenta growth factor and P1GF receptors in human meningiomas. J. Pathol. 189: 66.
16. Dragovich T., Rudin C.M., and Thompson C.B. 1998. Signal transduction pathways that regulate cell survival and cell death. Oncogene 17: 3207.
17. Eriksson A., Cao R., Pawliuk R., Berg S.-M., Tsang M.L., Zhou D., Fleet C., Tritsaris K., SDissing S., Leboulch P., and Cao Y. 2002. Placenta growth factor-1 antagonizes VEGF-induced angiogenesis and tumor growth by the formation of functionally inactive PGF-1/VEGF heterodimers. Cancer Cell 1: 99.
18. Ferrara N. 1999. Molecular and biological properties of vascular endothelial growth factor. J. Mol. Med. 77: 527.
19. Ferrara N., Carver-Moore K., Chen H., Dowd M., Lu L., O'Shea K.S., Powell-Braxton L., Hillan K.J., and Moore M.W. 1996. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 380: 439.
20. Fisher S.A., Langille B.L., and Srivastava D. 2000. Apoptosis during cardiovascular development. Circ. Res. 87: 856.
21. Folkman J. and D'Amore P.A. 1996. Blood vessel formation: What is its molecular basis? (comment). Cell 87: 1153.
22. Forsythe J.A., Jiang B.H., Iyer N.V., Agani F., Leung S.W., Koos R.D., and Semenza G.L. 1996. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol. Cell. Biol. 16: 4604.
23. Fujio Y. and Walsh K. 1999. Akt mediates cytoprotection of endothelial cells by vascular endothelial growth factor in an anchorage-dependent manner. J. Biol. Chem. 274: 16349.
24. Fukumura D., Xavier R., Sugiura T., Chen Y., Park E.C., Lu N., Selig M., Nielsen G., Taksir T., Jain R.K., and Seed B. 1998. Tumor induction of VEGF promoter activity in stromal cells. Cell 94: 715.
25. Fulton D., Gratton J.P., McCabe T.J., Fontana J., Fujio Y., Walsh K., Franke T.F., Papapetropoulos A., and Sessa W.C. 1999. Regulation of endothelium-derived nitric oxide production by the protein kinase Akt (erratum in Nature [1999] 400: 792). Nature 399: 597.
26. Gerber H.P., Dixit V., and Ferrara N. 1998. Vascular endothelial growth factor induces expression of the antiapoptotic proteins Bcl-2 and A1 in vascular endothelial cells. J. Biol. Chem. 273: 13313.
27. Gerber H.P., Hillan K.J., Ryan A.M., Kowalski J., Keller G.A., Rangell L., Wright B.D., Radtke F., Aguet M., and Ferrara N. 1999. VEGF is required for growth and survival in neonatal mice. Development 126: 1149.
28. Gratton J.P., Morales-Ruiz M., Kureishi Y., Fulton D., Walsh K., and Sessa W.C. 2001. Akt down-regulation of p38 signaling provides a novel mechanism of vascular endothelial growth factor-mediated cytoprotection in endothelial cells. J. Biol. Chem. 276: 30359.
29. Guo N., Krutzsch H.C., Inman J.K., and Roberts D.D. 1997. Thrombospondin 1 and type I repeat peptides of thrombospondin 1 specifically induce apoptosis of endothelial cells. Cancer Res. 57: 1735.
30. Hattori K., Heissig B., Wu Y., Dias S., Tejada R., Ferris B., Hicklin D.J., Zhu Z., Bohlen P., Witte L., Hendrikx J., Hackett N.R., Crystal R.G., Moore M.A., Werb Z., Lyden D., and Rafii S. 2002. Placental growth factor reconstitutes hematopoiesis by recruiting VEGFR1(+) stem cells from bone-marrow microenvironment. Nat. Med. 1: 1.
31. Hellstrom M., Kal n M., Lindahl P., Abramsson A., and Betsholtz C. 1999. Role of PDGF-B and PDGFR-beta in recruitment of vascular smooth muscle cells and pericytes during embryonic blood vessel formation in the mouse. Development 126: 3047.
32. Hirschi K.K., Rohovsky S.A., Beck L.H., Smith S.R., and D'Amore P.A. 1999. Endothelial cells modulate the proliferation of mural cell precursors via platelet-derived growth factor-BB and heterotypic cell contact. Circ. Res. 84: 298.
33. Holash J., Wiegand S.J., and Yancopoulos G.D. 1999a. New model of tumor angiogenesis: Dynamic balance between vessel regression and growth mediated by angiopoietins and VEGF. Oncogene 18: 5356.
34. Holash J., Maisonpierre P.C., Compton D., Boland P., Alexander C.R., Zagzag D., Yancopoulos G.D., and Wiegand S.J. 1999b. Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF. Science 284: 1994.
35. Ikeda E., Achen M.G., Breier G., and Risau W. 1995. Hypoxia-induced transcriptional activation and increased mRNA stability of vascular endothelial growth factor in C6 glioma cells. J. Biol. Chem. 270: 19761.
36. Ilan N., Mahooti S., and Madri J.A. 1998. Distinct signal transduction pathways are utilized during the tube formation and survival phases of in vitro angiogenesis. J. Cell. Sci. 111: 3621.
37. Isner J.M. and Asahara T. 1999. Angiogenesis and vasculogenesis as therapeutic strategies for postnatal neovascularization. J. Clin. Invest. 103: 1231.
38. Jacobson M.D., Weil M., and Raff M.C. 1997. Programmed cell death in animal development. Cell 88: 347.
39. Jiang B.H., Zheng J.Z., Aoki M., and Vogt P.K. 2000. Phosphatidylinositol 3-kinase signaling mediates angiogenesis and expression of vascular endothelial growth factor in endothelial cells. Proc. Natl. Acad. Sci. 97: 1749.
40. Khaliq A., Li X.F., Shams M., Sisi P., Acevedo C.A., Whittle M.J., Weich H., and Ahmed A. 1996. Localisation of placenta growth factor (P1GF) in human term placenta. Growth Factors 13: 243.
41. Kim K.J., Li B., Winer J., Armanini M., Gillett N., Phillips H.S., and Ferrara N. 1993. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo. Nature 362: 841.
42. Kuida K., Zheng T.S., Na S., Kuan C., Yang D., Karasuyama H., Rakic P., and Flavell R.A. 1996. Decreased apoptosis in the brain and premature lethality in CPP32-deficient mice. Nature 384: 368.
43. Leveen P., Pekny M., Gebre Medhin S., Swolin B., Larsson E., and Betsholtz C. 1994. Mice deficient for PDGF B show renal, cardiovascular, and hematological abnormalities. Genes Dev. 8: 1875.
44. Levy A.P., Levy N.S., Wegner S., and Goldberg M.A. 1995. Transcriptional regulation of the rat vascular endothelial growth factor gene by hypoxia. J. Biol. Chem. 270: 13333.
45. Lindahl P., Johansson B.R., Leveen P., and Betsholtz C. 1997. Pericyte loss and microaneurysm formation in PDGF-B-deficient mice. Science 277: 242.
46. Luttun A., Tjwa M., Moons L., Wu Y., Angelillo-Scherrer A., Liao F., Nagy J.A., Hooper A., Priller J., De Klerck B., Compernolle V., Daci E., Bohlen P., Dewerchin M., Herbert J.M., Fava R., Matthys P., Carmeliet G., Collen D., Dvorak H.F., Hicklin D.J., and Carmeliet P. 2002. Revascularization of ischemic tissues by P1GF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1. Nat. Med. 8: 831.
47. Mazure N.M., Chen E.Y., Laderoute K.R., and Giaccia A.J. 1997. Induction of vascular endothelial growth factor by hypoxia is modulated by a phosphatidylinositol 3-kinase/Akt signaling pathway in Ha-ras-transformed cells through a hypoxia inducible factor-1 transcriptional element. Blood 90: 3322.
48. McLeod D.S., Brownstein R., and Lutty G.A. 1996. Vaso-obliteration in the canine model of oxygen-induced retinopathy. Invest. Ophthalmol. Vis. Sci. 37: 300.
49. Michell B.J., Griffiths J.E., Mitchelhill K.I., Rodriguez-Crespo I., Tiganis T., Bozinovski S., de Montellano P.R., Kemp B.E., and Pearson R.B. 1999. The Akt kinase signals directly to endothelial nitric oxide synthase. Curr. Biol. 9: 845.
50. Millauer B., Longhi M.P., Plate K.H., Shawver L.K., Risau W., Ullrich A., and Strawn L.M. 1996. Dominant-negative inhibition of Flk-1 suppresses the growth of many tumor types in vivo. Cancer Res. 56: 1615.
51. Morales-Ruiz M., Fulton D., Sowa G., Languino L.R., Fujio Y., Walsh K., and Sessa W.C. 2000. Vascular endothelial growth factor-stimulated actin reorganization and migration of endothelial cells is regulated via the serine/threonine kinase Akt. Circ. Res. 86: 892.
52. Neufeld G., Cohen T., Gengrinovitch S., and Poltorak Z. 1999. Vascular endothelial growth factor (VEGF) and its receptors. FASEB J 13: 9.
53. Nomura M., Yamagishi S., Harada S., Yamashima T., Yamashita J., and Yamamoto H. 1998. Placenta growth factor (P1GF) mRNA expression in brain tumors. J. Neurooncol. 40: 123.
54. Nor J.E., Christensen J., Mooney D.J., and Polverini P.J. 1999. Vascular endothelial growth factor (VEGF)-mediated anglogenesis is associated with enhanced endothelial cell survival and induction of Bcl-2 expression. Am. J. Pathol. 154: 375.
55. O'Connor D.S., Schechner J.S., Adida C., Mesri M., Rothermel A.L., Li F., Nath A.K., Pober J.S., and Altieri D.C. 2000. Control of apoptosis during angiogenesis by survivin expression in endothelial cells. Am. J. Pathol. 156: 393.
56. O'Reilly M.S., Boehm T., Shing Y., Fukai N., Vasios G., Lane W.S., Flynn E., Birkhead J.R., Olsen B.R., and Folkman J. 1997. Endostatin: An endogenous inhibitor of angiogenesis and tumor growth. Cell 88: 277.
57. Orlidge A. and D'Amore P.A. 1987. Inhibition of capillary endothelial cell growth by pericytes and smooth muscle cells. J. Cell Biol. 105: 1455.
58. Ozaki H., Seo M.S., Ozaki K., Yamada H., Yamada E., Okamoto N., Hofmann F., Wood J.M., and Campochiaro P.A. 2000. Blockade of vascular endothelial cell growth factor receptor signaling is sufficient to completely prevent retinal neovascularization. Am. J. Pathol. 156: 697.
59. Papetti M. and Herman I.M. 2002. Mechanisms of normal and tumor-derived angiogenesis. Am. J. Physiol. Cell Physiol. 282: C947.
60. Patan S. 2000. Vasculogenesis and angiogenesis as mechanisms of vascular network formation, growth and remodeling. J. Neurooncol. 50: 1.
61. Pierce E.A., Avery R.L., Foley E.D., Aiello L.P., and Smith L.E. 1995. Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization. Proc. Natl. Acad. Sci. 92: 905.
62. Pietsch T., Valter M.M., Wolf H.K., von Deimling A., Huang H.J., Cavenee W.K., and Wiestler O.D. 1997. Expression and distribution of vascular endothelial growth factor protein in human brain tumors. Acta. Neuropathol. 93: 109.
63. Radisavljevic Z., Avraham H., and Avraham S. 2000. Vascular endothelial growth factor regulates ICAM-1 expression via phosophatidylinositol 3 OH kinase-/AKT/Nitric oxide pathway and modulates migration of brain microvascular endothelial cells. J. Biol. Chem. 275: 20770.
64. Reinmuth N., Liu W., Jung Y.D., Ahmad S.A., Shaheen R.M., Fan F., Bucana C.D., McMahon G., Gallick G.E., and Ellis L.M. 2001. Induction of VEGF in perivascular cells defines a potential paracrine mechanism for endothelial cell survival. FASEB J. 15: 1239.
65. Risau W. 1997. Mechanisms of angiogenesis. Nature 386: 671.
66. Robbins S.G., Rajaratnam V.S., and Penn J.S. 1998. Evidence for upregulation and redistribution of vascular endothelial growth factor (VEGF) receptors fit-1 and flk-1 in the oxygen-injured rat retina. Growth Factors 16: 1.
67. Senger D.R., Perruzzi C.A., Feder J., and Dvorak H.F. 1986. A highly conserved vascular permeability factor secreted by a variety of human and rodent tumor cell lines. Cancer Res. 46: 5629.
68. Seo M.S., Kwak N., Ozaki H., Yamada H., Okamoto N., Yamada E., Fabbro D., Hofmann F., Wood J.M., and Campochiaro P.A. 1999. Dramatic inhibition of retinal and choroidal neovascularization by oral administration of a kinase inhibitor. Am. J. Pathol. 154: 1743.
69. Shweiki D., Itin A., Soffer D., and Keshet E. 1992. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 359: 843.
70. Sim B.K., O'Reilly M.S., Liang H., Fortier A.H., He W., Madsen J.W., Lapcevich R., and Nacy C.A. 1997. A recombinant human angiostatin protein inhibits experimental primary and metastatic cancer. Cancer Res. 57: 1329.
71. Simpson D.A., Murphy G.M., Bhaduri T., Gardiner T.A., Archer D.B., and Stitt A.W. 1999. Expression of the VEGF gene family during retinal vaso-obliteration and hypoxia. Biochem. Biophys. Res. Commun. 262: 333.
72. Smith L.E., Wesolowski E., McLellan A., Kostyk S.K., D'Amato R., Sullivan R., and D'Amore P.A. 1994. Oxygen-induced retinopathy in the mouse. Invest. Ophthalmol. Vis. Sci. 35: 101.
73. Soker S., Takashima S., Miao H.Q., Neufeld G., and Klagsbrun M. 1998. Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor. Cell 92: 735.
74. Sone H., Kawakami Y., Segawa T., Okuda Y., Sekine Y., Honmura S., Suzuki H., Yamashita K., and Yamada N. 1999. Effects of intraocular or systemic administration of neutralizing antibody against vascular endothelial growth factor on the murine experimental model of retinopathy. Life Sci. 65: 2573.
75. Stein I., Neeman M., Shweiki D., Itin A., and Keshet E. 1995. Stabilization of vascular endothelial growth factor mRNA by hypoxia and hypoglycemia and coregulation with other ischemia-induced genes. Mol. Cell. Biol. 15: 5363.
76. Stein I., Itin A., Einat P., Skaliter R., Grossman Z., and Keshet E. 1998. Translation of vascular endothelial growth factor mRNA by internal ribosome entry: Implications for translation under hypoxia. Mol. Cell. Biol. 18: 3112.
77. Stone J., Itin A., Alon T., Pe'er J., Gnessin H., Chan-Ling T., and Keshet E. 1995. Development of retinal vasculature is mediated by hypoxia-induced vascular endothelial growth factor (VEGF) expression by neuroglia. J. Neurosci. 15: 4738.
78. Takashima S., Kitakaze M., Asakura M., Asanuma H., Sanada S., Tashiro F., Niwa H., Miyazaki Ji J., Hirota S., Kitamura Y., Kitsukawa T., Fujisawa H., Klagsbrun M., and Hori M. 2002. Targeting of both mouse neuropilin-1 and neuropilin-2 genes severely impairs developmental yolk sac and embryonic angiogenesis. Proc. Natl. Acad. Sci. 99: 3657.
79. Varner J.A. and Cheresh D.A. 1996. Tumor angiogenesis and the role of vascular cell integrin alphavbeta3. Important Adv. Oncol. 1996: 69.
80. Wu L.W., Mayo L.D., Dunbar J.D., Kessler K.M., Baerwald M.R., Jaffe E.A., Wang D., Warren R.S., and Donner D.B. 2000. Utilization of distinct signaling pathways by receptors for vascular endothelial cell growth factor and other mitogens in the induction of endothelial cell proliferation. J. Biol. Chem. 275: 5096.
81. Zachary I. 2001. Signaling mechanisms mediating vascular protective actions of vascular endothelial growth factor. Am. J. Physiol. Cell. Physiol. 280: C1375.